164 related articles for article (PubMed ID: 9299418)
1. Gamma linolenic acid regulates expression of maspin and the motility of cancer cells.
Jiang WG; Hiscox S; Horrobin DF; Bryce RP; Mansel RE
Biochem Biophys Res Commun; 1997 Aug; 237(3):639-44. PubMed ID: 9299418
[TBL] [Abstract][Full Text] [Related]
2. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
3. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
[TBL] [Abstract][Full Text] [Related]
4. Expression of the tumor suppressor gene Maspin in human pancreatic cancers.
Maass N; Hojo T; Ueding M; Lüttges J; Klöppel G; Jonat W; Nagasaki K
Clin Cancer Res; 2001 Apr; 7(4):812-7. PubMed ID: 11309327
[TBL] [Abstract][Full Text] [Related]
5. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
6. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix.
Ngamkitidechakul C; Burke JM; O'Brien WJ; Twining SS
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3135-41. PubMed ID: 11726614
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
9. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA).
Jiang WG; Hiscox S; Hallett MB; Horrobin DF; Mansel RE; Puntis MC
Cancer Res; 1995 Nov; 55(21):5043-8. PubMed ID: 7585549
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid.
Cai J; Jiang WG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 1999 Jan; 60(1):21-9. PubMed ID: 10319914
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
[TBL] [Abstract][Full Text] [Related]
13. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
Kim S; Han J; Kim J; Park C
Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Expression of catenins in human cancer cells and its regulation by n-6 polyunsaturated fatty acids.
Jiang WG; Hiscox S; Horrobin DF; Hallett MB; Mansel RE; Puntis MC
Anticancer Res; 1995; 15(6B):2569-73. PubMed ID: 8669825
[TBL] [Abstract][Full Text] [Related]
16. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
Zhang M; Maass N; Magit D; Sager R
Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
[TBL] [Abstract][Full Text] [Related]
17. Aberrant maspin expression in human endometrial cancer.
Murai S; Maesawa C; Masuda T; Sugiyama T
Cancer Sci; 2006 Sep; 97(9):883-8. PubMed ID: 16822296
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2010 Feb; 183(3):455-61. PubMed ID: 19944674
[TBL] [Abstract][Full Text] [Related]
20. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]